Related Experiment Videos
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence
Abstract:
p16CDKN2 specifically binds to and inhibits the cyclin-dependent kinases CDK4 and CDK6, which function as regulators of cell cycle progression in G1 by contributing to the phosphorylation of the retinoblastoma protein (pRB). Human cell lines lacking functional pRB contain high levels of p16 RNA and protein, suggesting a negative feedback loop by which pRB might regulate p16 expression in late G1. By a combination of nuclear run-on assays and promoter analyses in human fibroblasts expressing a temperature-sensitive simian virus 40 T antigen, we show that p16 transcription is affected by the status of pRB and define a region in the p16 promoter that is required for this response. However, the effect is not sufficient to account for the differences in p16 RNA levels between pRB-positive and -negative cells. Moreover, p16 RNA is extremely stable, and the levels do not change appreciably during the cell cycle. Primary human fibroblasts express very low levels of p16, but the RNA and protein accumulate in late-passage, senescent cells. The apparent overexpression of p16 in pRB-negative cell lines is therefore caused by at least two factors: loss of repression by pRB and an increase in the number of population doublings.
Insights
The retinoblastoma protein (pRB) influences p16 expression, with its absence leading to higher p16 levels. This study identifies a pRB-responsive region in the p16 promoter, but other factors also contribute to p16 accumulation in senescent cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- p16CDKN2 inhibits cyclin-dependent kinases CDK4 and CDK6, crucial for cell cycle G1 progression.
- The retinoblastoma protein (pRB) is phosphorylated by CDK4/6.
- Human cell lines lacking functional pRB exhibit elevated p16 RNA and protein levels, suggesting a negative feedback mechanism.
Purpose of the Study:
- To investigate the regulatory role of pRB in p16 expression.
- To identify the p16 promoter region responsive to pRB status.
- To understand the factors contributing to p16 accumulation in senescent cells.
Main Methods:
- Nuclear run-on assays were employed to assess p16 transcription.
- Promoter analyses were conducted in human fibroblasts expressing a temperature-sensitive simian virus 40 T antigen.
- p16 RNA stability and cell cycle expression levels were analyzed.
Main Results:
- pRB status affects p16 transcription, and a specific promoter region was identified as critical for this response.
- The observed effect of pRB on p16 transcription does not fully explain the high p16 levels in pRB-negative cells.
- p16 RNA exhibits high stability and minimal cell cycle-dependent variation.
- Primary fibroblasts show low p16 expression, which increases in senescent cells.
Conclusions:
- pRB negatively regulates p16 expression via its promoter.
- p16 accumulation in pRB-negative cells is attributed to both loss of pRB repression and increased population doublings leading to senescence.
- p16 plays a role in cellular senescence, independent of pRB status.